We are live on ! Find out more
BDF

Balasa Dinverno & Foltz Portfolio holdings

AUM $1.58B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
AUM
$1.39B
AUM Growth
+$142M
Cap. Flow
+$504M
Cap. Flow %
36.3%
Top 10 Hldgs %
62.1%
Holding
339
New
34
Increased
132
Reduced
122
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 6.74%
2 Financials 4.08%
3 Healthcare 3.78%
4 Communication Services 2.4%
5 Consumer Staples 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAST icon
126
Fastenal
FAST
$60.6B
$975K 0.07%
37,498
-1,254
-3% -$32.6K
JLL icon
127
Jones Lang LaSalle
JLL
$16.6B
$959K 0.07%
4,906
+386
+9% +$75.4K
HZNP
128
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$956K 0.07%
10,207
-575
-5% -$52.9K
AN icon
129
AutoNation
AN
$6.92B
$917K 0.07%
9,677
+106
+1% +$10.4K
HUM icon
130
Humana
HUM
$45.4B
$899K 0.06%
2,031
+246
+14% +$107K
BHF icon
131
Brighthouse Financial
BHF
$3.43B
$877K 0.06%
19,254
-1,466
-7% -$68.9K
TMHC
132
DELISTED
Taylor Morrison
TMHC
$872K 0.06%
32,998
-3,678
-10% -$109K
HPE icon
133
Hewlett Packard
HPE
$72.5B
$836K 0.06%
57,355
+4,088
+8% +$64.6K
CNXC icon
134
Concentrix
CNXC
$1.56B
$820K 0.06%
5,100
-140
-3% -$21.5K
UTHR icon
135
United Therapeutics
UTHR
$22.6B
$816K 0.06%
4,549
-590
-11% -$112K
OMF icon
136
OneMain Financial
OMF
$7.34B
$801K 0.06%
13,369
-700
-5% -$39.6K
BIIB icon
137
Biogen
BIIB
$30.4B
$800K 0.06%
2,310
-880
-28% -$267K
GS icon
138
Goldman Sachs
GS
$302B
$791K 0.06%
2,084
+258
+14% +$92.3K
AVGO icon
139
Broadcom
AVGO
$2T
$783K 0.06%
16,420
+470
+3% +$21.8K
SNX icon
140
TD Synnex
SNX
$20.6B
$775K 0.06%
6,362
+1,122
+21% +$138K
VIG icon
141
Vanguard Dividend Appreciation ETF
VIG
$115B
$769K 0.06%
4,970
-131
-3% -$20.1K
VV icon
142
Vanguard Morningstar Large-Cap ETF
VV
$54.4B
$767K 0.06%
3,821
CMC icon
143
Commercial Metals
CMC
$7.99B
$761K 0.05%
24,768
-1,165
-4% -$36.1K
VBR icon
144
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
$754K 0.05%
4,339
+3
+0.1% +$520
CRNC icon
145
Cerence
CRNC
$382M
$752K 0.05%
7,051
-329
-4% -$32.4K
NRG icon
146
NRG Energy
NRG
$25.5B
$743K 0.05%
18,431
-14,281
-44% -$517K
VWO icon
147
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$738K 0.05%
13,595
+374
+3% +$19.9K
PM icon
148
Philip Morris
PM
$289B
$737K 0.05%
7,441
+698
+10% +$67K
TMUS icon
149
T-Mobile US
TMUS
$194B
$730K 0.05%
5,042
+17
+0.3% +$2.34K
RITM icon
150
Rithm Capital
RITM
$5.75B
$729K 0.05%
68,875
-3,795
-5% -$40.3K

Similar funds

Balasa Dinverno & Foltz's Q2 2021 Portfolio in Review

As of Q2 2021, Balasa Dinverno & Foltz held 339 positions worth $1.39B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Balasa Dinverno & Foltz deployed $504M of net new capital in Q2 2021, opening 34 new positions and adding to 132 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 1,100 shares worth $4.61M.

By sector, the portfolio is most concentrated in Technology at 6.7% of assets, down from 6.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Goldman Sachs Access Treasury 0-1 Year ETF, an estimated $3.27M trimmed.

  • Balasa Dinverno & Foltz's largest Q2 2021 buy was Berkshire Hathaway Class A: 1,100 shares worth $4.61M.
  • Balasa Dinverno & Foltz added most to iShares MSCI USA Quality Factor ETF in Q2 2021, an estimated $3.35M increase.
  • Balasa Dinverno & Foltz's biggest Q2 2021 reduction was Goldman Sachs Access Treasury 0-1 Year ETF, cutting an estimated $3.27M.
  • Balasa Dinverno & Foltz fully exited Vanguard Tax-Exempt Bond Index Fund in Q2 2021, selling an estimated $6.81M.
  • Balasa Dinverno & Foltz's ten largest holdings make up 62% of its $1.39B portfolio in Q2 2021.
  • Balasa Dinverno & Foltz opened 34 new positions and closed 10 in Q2 2021.
  • Balasa Dinverno & Foltz's portfolio value rose 11% quarter-over-quarter to $1.39B.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2021, filed 23 Jul 2021.